BioMarx raises €805K Pre-Seed round
5 January 2026· Belfast, United Kingdom· health, diagnostics, biotech, b2b, software_hardware
The capital will support the transition from proof of concept to a minimum viable product (MVP), pursuit of ISO 13485 accreditation, and the conduct of a preliminary lab-based clinical study for its lung cancer liquid biopsy test.
Investors
LeadSFC Capital
Also participating
angel investorsClarendon Fund ManagersUniversity of StrathclydeInterTradeIrelandTechstart Ventures
About BioMarx
Stage
Pre-Seed
Headquarters
Belfast, United Kingdom
Founded
2025
Team Size
6–20
Sectors
healthdiagnosticsbiotechb2bsoftware_hardware
Source: https://thetopvoices.com/biomarx-secures-700k-to-advance-genomic-medicine-platform/